Back

Electrostatic-driven Interactions Enhance Intratumoral Retention and Antitumor Efficacy of Immune Checkpoint Blockade Antibodies

Mohanty, R. P.; Pan, Y.; Lewis, M. M.; Soto, M. R.; Maier, E. Y.; Alzhrani, R. F.; Ghosh, D.

2023-12-23 bioengineering
10.1101/2023.12.22.573144 bioRxiv
Show abstract

Tumor extracellular matrix (ECM) forms a net negative charged network that interacts with and hinders the transport of molecules partly based on electrostatic interactions. The focus on drug delivery in solid tumors has traditionally been on developing neutral charge coatings to minimize interactions with the ECM for improved transport. In contrast to this prior work, we recently found a cationic peptide that interacted electrostatically with the negatively charged components of the ECM, resulting in enhanced uptake and retention of nanoparticles in tumor ECM and tumor tissue. Based on this previous study, here, we hypothesize that the electrostatically driven interactions of the cationic peptide will improve the binding and retention of immune checkpoint blockade antibodies (ICBs), ultimately enhancing their antitumor immunogenic responses. We prepared peptide antibody (Ab) conjugates by conjugating the cationic peptide to ICBs, anti-cytotoxic T lymphocyte antigen 4 ({propto}-CTLA4) and anti-programmed cell death ligand-1 ({propto}-PD-L1) Abs, using copper-free click chemistry. We confirmed an average of 1 - 2 peptides per Ab. The cationic peptide electrostatically interacted with the net negatively charged tumor ECM and improved the binding of the Abs to the tumor ECM without affecting their antigen recognition capacities. Modifying the Abs due to cationic peptide conjugation reduced the systemic exposure of the Abs and did not induce treatment-related toxicities. We quantified a significantly higher population of tumor-infiltrating CD8+ T cells and a significant depletion of regulatory T cells in the tumor and tumor-draining lymph nodes upon peptide conjugation, which resulted in a better therapeutic outcome of the ICBs. ONE SENTENCE SUMMARYElectrostatic interaction-based intratumoral retention enhances antitumor responses of immune checkpoint blockade antibodies upon local administration.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Advanced Therapeutics
17 papers in training set
Top 0.1%
11.8%
2
Bioconjugate Chemistry
20 papers in training set
Top 0.1%
9.6%
3
Advanced Healthcare Materials
85 papers in training set
Top 0.5%
4.8%
4
Bioengineering & Translational Medicine
21 papers in training set
Top 0.1%
4.3%
5
Journal of Controlled Release
44 papers in training set
Top 0.3%
4.3%
6
Biomaterials
84 papers in training set
Top 0.4%
4.3%
7
Cellular and Molecular Bioengineering
22 papers in training set
Top 0.1%
3.2%
8
ACS Biomaterials Science & Engineering
37 papers in training set
Top 0.3%
3.1%
9
ACS Applied Materials & Interfaces
39 papers in training set
Top 0.3%
2.8%
10
Nature Communications
5641 papers in training set
Top 39%
2.6%
50% of probability mass above
11
ACS Applied Bio Materials
24 papers in training set
Top 0.3%
2.4%
12
ACS Chemical Biology
167 papers in training set
Top 1%
2.4%
13
Molecular Therapy
81 papers in training set
Top 0.8%
2.1%
14
ACS Central Science
71 papers in training set
Top 0.6%
2.1%
15
Advanced Science
286 papers in training set
Top 4%
2.1%
16
ACS Nano
113 papers in training set
Top 1%
1.9%
17
Scientific Reports
3612 papers in training set
Top 51%
1.9%
18
Bioactive Materials
20 papers in training set
Top 0.3%
1.7%
19
Molecular Pharmaceutics
16 papers in training set
Top 0.2%
1.7%
20
Molecular Therapy Nucleic Acids
39 papers in training set
Top 0.5%
1.7%
21
Biomacromolecules
29 papers in training set
Top 0.3%
1.3%
22
Journal of Biomedical Materials Research Part A
20 papers in training set
Top 0.4%
1.1%
23
Advanced Materials
56 papers in training set
Top 0.8%
1.1%
24
iScience
1154 papers in training set
Top 26%
1.1%
25
Antibody Therapeutics
16 papers in training set
Top 0.2%
1.1%
26
Advanced Functional Materials
46 papers in training set
Top 1.0%
1.0%
27
ACS Omega
105 papers in training set
Top 4%
0.8%
28
Frontiers in Immunology
638 papers in training set
Top 10%
0.8%
29
Theranostics
37 papers in training set
Top 1%
0.8%
30
Acta Biomaterialia
92 papers in training set
Top 1%
0.8%